Technology

Amneal Pharmaceuticals

$4.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+2.26%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AMRX and other stocks, options, and ETFs commission-free!

About AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock, also called Amneal Pharmaceuticals, is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. The listed name for AMRX is Amneal Pharmaceuticals, Inc. Class A Common Stock.

CEO
Chintu Patel
Employees
5,500
Headquarters
Bridgewater, New Jersey
Founded
2002
Market Cap
1.46B
Price-Earnings Ratio
12.15
Dividend Yield
—
Average Volume
1.13M
High Today
$5.00
Low Today
$4.80
Open Price
$4.84
Volume
1.19M
52 Week High
$5.56
52 Week Low
$2.40

Collections

AMRX Earnings

$0.00
$0.07
$0.13
$0.20
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

KWR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure